A detailed history of Lathrop Investment Management Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Lathrop Investment Management Corp holds 4,273 shares of ABBV stock, worth $724,828. This represents 0.16% of its overall portfolio holdings.

Number of Shares
4,273
Previous 3,773 13.25%
Holding current value
$724,828
Previous $647,000 30.45%
% of portfolio
0.16%
Previous 0.13%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $81,920 - $99,665
500 Added 13.25%
4,273 $844,000
Q1 2023

Apr 20, 2023

SELL
$144.61 - $166.54 $60,013 - $69,114
-415 Reduced 9.91%
3,773 $601,000
Q4 2022

Jan 17, 2023

BUY
$138.31 - $165.87 $57,398 - $68,836
415 Added 11.0%
4,188 $677,000
Q1 2021

Apr 19, 2021

SELL
$102.3 - $112.62 $11,662 - $12,838
-114 Reduced 2.93%
3,773 $408,000
Q4 2020

Jan 26, 2021

BUY
$80.49 - $108.67 $27,286 - $36,839
339 Added 9.55%
3,887 $416,000
Q3 2020

Oct 19, 2020

SELL
$85.91 - $100.83 $8,591 - $10,083
-100 Reduced 2.74%
3,548 $311,000
Q2 2020

Jul 30, 2020

SELL
$73.37 - $98.18 $17,241 - $23,072
-235 Reduced 6.05%
3,648 $358,000
Q1 2020

Apr 15, 2020

SELL
$64.5 - $97.79 $203,949 - $309,211
-3,162 Reduced 44.88%
3,883 $296,000
Q4 2019

Jan 24, 2020

SELL
$72.13 - $90.25 $216 - $270
-3 Reduced 0.04%
7,045 $624,000
Q1 2019

Apr 19, 2019

SELL
$77.14 - $90.79 $9,642 - $11,348
-125 Reduced 1.74%
7,048 $568,000
Q4 2018

Feb 08, 2019

BUY
$77.85 - $96.01 $90,928 - $112,139
1,168 Added 19.45%
7,173 $661,000
Q3 2018

Oct 29, 2018

SELL
$88.91 - $98.84 $6,223 - $6,918
-70 Reduced 1.15%
6,005 $568,000
Q1 2018

Apr 16, 2018

BUY
$92.01 - $123.21 $17,941 - $24,025
195 Added 3.32%
6,075 $575,000
Q3 2017

Oct 11, 2017

BUY
$69.85 - $89.22 $410,717 - $524,613
5,880
5,880 $522,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $300B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Lathrop Investment Management Corp Portfolio

Follow Lathrop Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lathrop Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lathrop Investment Management Corp with notifications on news.